Anti-Obesity Effect of Lactobacillus gasseri BNR17 in High-Sucrose Diet-Induced Obese Mice

University of Bremen, Germany
PLoS ONE (Impact Factor: 3.23). 01/2013; 8(1):e54617. DOI: 10.1371/journal.pone.0054617
Source: PubMed


Previously, we reported that Lactobacillus gasseri BNR17 (BNR17), a probiotic strain isolated from human breast milk, inhibited increases in body weight and adipocyte tissue weight in high-sucrose diet-fed Sprague-Dawley (SD) rats and reduced glucose levels in type 2 diabetes mice. In the current study, we conducted further experiments to extend these observations and elucidate the mechanism involved. C57BL/6J mice received a normal diet, high-sucrose diet or high-sucrose diet containing L. gasseri BNR17 (10(9) or 10(10) CFU) for 10 weeks. The administration of L. gasseri BNR17 significantly reduced the body weight and white adipose tissue weight regardless of the dose administered. In BNR17-fed groups, mRNA levels of fatty acid oxidation-related genes (ACO, CPT1, PPARα, PPARδ) were significantly higher and those of fatty acid synthesis-related genes (SREBP-1c, ACC) were lower compared to the high-sucrose-diet group. The expression of GLUT4, main glucose transporter-4, was elevated in BNR17-fed groups. L. gasseri BNR17 also reduced the levels of leptin and insulin in serum. These results suggest that the anti-obesity actions of L. gasseri BNR17 can be attributed to elevated expression of fatty acid oxidation-related genes and reduced levels of leptin. Additionally, data suggested the anti-diabetes activity of L. gasseri BNR17 may be to due elevated GLUT4 and reduced insulin levels.

79 Reads
  • Source
    • "These bacteria have 100-times more genes than the human genome (Qin et al., 2010), including genes that provide additional benefits to the host. For example, the intestinal microbiota has several indispensible roles for mammals, such as vitamin K and B production, food processing, digestion of complex indigestible polysaccharides, etc. Intestinal microbiota also has a significant impact on human health through enhancement of intestinal function, modulation of immune system and hypocholesterolemic effects (Kang et al., 2013). The generation of germ free (GF) animals was a valuable tool for elucidating the true impact of microbiota. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Abstract Recent reports suggest that the metabolic activity of the enteric microbiota may influence the fatty acid composition of the host tissue. There are many studies dealing with the influence of lactobacilli on various pathological conditions, and some of the effects are strain-specific. This study was designed to test the effects of a particular Lactobacillus strain, Lactobacillus rhamnosus LA68 on fatty acid composition of the liver and the brain of C57BL/6 mice in the absence of an underlying pathological condition. Female mice were supplemented with live L. rhamnosus LA68 bacteria for the duration of 1 month. Serum biochemistry was analyzed and liver and brain fatty acid composition was assessed by gas-liquid chromatography. Significant changes in liver and brain fatty acid composition were detected. In the liver tissue we detected an increase in palmitoleic acid (p = 0.038), while in the brain compartment we found an increase in palmitic (p = 0.042), stearic (p = 0.017), arachidonic acid (p = 0.009) and docosahexaenoic acid (p = 0.004) for control versus experimental group. These results show discrete changes caused by LA68 strain consumption. Even short duration of administration of LA68 influences the fatty acid composition of the host which adds to the existing knowledge about Lactobacillus host interaction, and adds to the growing knowledge of metabolic intervention possibilities.
    International Journal of Food Sciences and Nutrition 11/2014; 66(1):1-5. DOI:10.3109/09637486.2014.979313 · 1.21 Impact Factor
  • Source
    • "Elevated expression of fatty acid oxidation-related genes and reduced levels of leptin, elevated GLUT4 and reduced insulin levels Reduced the body weight and white adipose tissue weight Kang et al. 2013 L. plantarum (LP14) "
    [Show abstract] [Hide abstract]
    ABSTRACT: The prevalence of obesity is rapidly becoming endemic in industrialized countries and continues to increase in developing countries worldwide. Obesity predisposes people to an increased risk of developing metabolic syndrome. Recent studies have described an association between obesity and certain gut microbiota, suggesting that gut microbiota might play a critical role in the development of obesity. Although probiotics have many beneficial health effects in humans and animals, attention has only recently been drawn to manipulating the gut microbiota, such as lactic acid bacteria (LAB), to influence the development of obesity. In this review, we first describe the causes of obesity, including the genetic and environmental factors. We then describe the relationship between the gut microbiota and obesity, and the mechanisms by which the gut microbiota influence energy metabolism and inflammation in obesity. Lastly, we focus on the potential role of LAB in mediating the effects of the gut microbiota in the development of obesity.
    Applied Microbiology and Biotechnology 11/2013; 98(1). DOI:10.1007/s00253-013-5346-3 · 3.34 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Worldwide obesity has reached a pandemic proportion. World Health Organization (WHO) estimates that by 2020, two thirds of the global disease burden will be attributable to obesity and obesity associated complications. Existing anti-obesity drugs, affecting one of the fundamental processes of the weight regulation in human body, have displayed serious side effects which outweigh their beneficial effects. Clinical and non-clinical researchers in this area are now facing a challenge to search for non-pharmacological alternatives for the prevention of obesity. Dietary interventions and life style changes with enhanced physical activity are two such options. Considering the importance of dietary interventions, the present review highlights the role, significance and potential of functional food ingredients for the management of obesity and associated co-morbidities.
    Journal of Functional Foods 07/2013; 5(3):997–1012. DOI:10.1016/j.jff.2013.04.014 · 3.57 Impact Factor
Show more

Preview (2 Sources)

79 Reads
Available from